| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/01/1998 | EP0832237A1 Isospora suis vaccine |
| 04/01/1998 | EP0832236A1 Methods for enhancement of protective immune responses |
| 04/01/1998 | EP0832235A1 HIGH METHIONINE DERIVATIVES OF alfa-HORDOTHIONIN |
| 04/01/1998 | EP0832234A2 Genetic control of flowering |
| 04/01/1998 | EP0832233A1 Human chemokine beta-13 |
| 04/01/1998 | EP0832232A1 Kunitz type plasma kallikrein inhibitors |
| 04/01/1998 | EP0832231A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
| 04/01/1998 | EP0832230A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 04/01/1998 | EP0832229A2 Cd40l mutein |
| 04/01/1998 | EP0832228A1 Modified hemoglobin-like compounds and methods of purifying same |
| 04/01/1998 | EP0832227A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
| 04/01/1998 | EP0832226A2 Ebnerin cloning of a secreted von ebner's gland protein |
| 04/01/1998 | EP0832225A1 Chimeric proteins for use in transport of a selected substance into cells |
| 04/01/1998 | EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
| 04/01/1998 | EP0832222A2 Linc-53 from c. elegans and its uses in listing compounds involved in the control of cell behaviour and pharmaceutical compositions |
| 04/01/1998 | EP0832221A1 Bone stimulating factor |
| 04/01/1998 | EP0832220A1 Ob protein compositions and method |
| 04/01/1998 | EP0832219A2 Chimeric leptin fused to immunoglobulin domain and use |
| 04/01/1998 | EP0832218A1 Avian ghd genes and their use in methods for sex identification in birds |
| 04/01/1998 | EP0832217A1 Modified steroid hormones for gene therapy and methods for their use |
| 04/01/1998 | EP0832216A1 Fibroblast growth factor 15 |
| 04/01/1998 | EP0832215A1 Fibroblast growth factor 11 |
| 04/01/1998 | EP0832205A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models |
| 04/01/1998 | EP0832204A1 Treatment of insulin resistance |
| 04/01/1998 | EP0832199A1 Fucosyltransferase genes and uses thereof |
| 04/01/1998 | EP0832191A1 Recombinant viral nucleic acids |
| 04/01/1998 | EP0832189A1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 04/01/1998 | EP0832185A1 Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
| 04/01/1998 | EP0832150A1 Cascade polymers with iodine-containing aromatic compounds |
| 04/01/1998 | EP0832135A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES |
| 04/01/1998 | EP0832134A1 Anti-allergy bispecific molecules |
| 04/01/1998 | EP0832133A1 Monoclonal antibody detection of proteins on sperm related to fertility |
| 04/01/1998 | EP0832132A1 Lymphocyte chemoattractant factor and uses thereof |
| 04/01/1998 | EP0832131A1 Separating unmodified hemoglobin from cross-linked hemoglobin |
| 04/01/1998 | EP0832130A1 Separation of hemoglobin on hydroxyapatite using hplc |
| 04/01/1998 | EP0832129A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders |
| 04/01/1998 | EP0832128A2 Thrombin receptor homolog |
| 04/01/1998 | EP0832127A2 Synthetic peptides and pharmaceutical compositions comprising them |
| 04/01/1998 | EP0832126A1 G-protein receptor htnad29 |
| 04/01/1998 | EP0832125A1 Human g-protein receptor hgber32 |
| 04/01/1998 | EP0832124A1 Human amine receptor |
| 04/01/1998 | EP0832123A1 G-protein parathyroid hormone receptor hltdg74 |
| 04/01/1998 | EP0832122A1 Human g-protein receptor hpraj70 |
| 04/01/1998 | EP0832121A1 Methods for purifying authentic igf from yeast hosts |
| 04/01/1998 | EP0832120A2 Anti-fungal d-amino acid histatin-based peptides |
| 04/01/1998 | EP0832119A2 Anti-fungal and anti-bacterial histatin-based peptides |
| 04/01/1998 | EP0832118A2 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 04/01/1998 | EP0832117A1 Ligand-stimulated gene expression |
| 04/01/1998 | EP0832116A1 New dna molecules |
| 04/01/1998 | EP0832115A1 PROMOTION OF HOMOLOGOUS DNA PAIRING BY RecA-DERIVED PEPTIDES |
| 04/01/1998 | EP0832114A2 Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus |
| 04/01/1998 | EP0832113A2 Peptides for hiv-1 detection |
| 04/01/1998 | EP0832112A1 Monocyte chemotactic protein-4 |
| 04/01/1998 | EP0832110A1 Antiviral peptoid compounds |
| 04/01/1998 | EP0832109A1 Fibroblast growth factor homologous factor-2 and methods of use |
| 04/01/1998 | EP0832098A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 04/01/1998 | EP0832095A1 A method of cross-linking amino acid-containing polymers using photoactivatable chemical cross-linkers |
| 04/01/1998 | EP0832093A1 Expression of lipoproteins |
| 04/01/1998 | EP0832081A1 Bicyclic-aromatic compounds |
| 04/01/1998 | EP0832068A1 Stable reagents for the preparation of radiopharmaceuticals |
| 04/01/1998 | EP0831940A1 Hiv-1 prophylactic composition and method |
| 04/01/1998 | EP0831938A1 Radiolabeled peptide compositions for site-specific targeting |
| 04/01/1998 | EP0831937A1 Immunological combination compositions and methods |
| 04/01/1998 | EP0831936A1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 04/01/1998 | EP0831925A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/01/1998 | EP0831923A1 Separation of active complexes |
| 04/01/1998 | EP0831922A2 Improved pharmaceutical compositions for gene therapy |
| 04/01/1998 | EP0831921A1 Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 04/01/1998 | EP0831903A1 Connective tissue growth factor |
| 04/01/1998 | EP0831902A1 Muscle trophic factor |
| 04/01/1998 | EP0831900A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
| 04/01/1998 | EP0831899A1 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (rhdv)] compositions and uses |
| 04/01/1998 | EP0831895A1 Tumor associated epitopes |
| 04/01/1998 | EP0831886A1 Thrombopoietin compositions |
| 04/01/1998 | EP0831885A1 Methods and uses of connective tissue growth factor as an induction agent |
| 04/01/1998 | EP0831884A1 Methods and compositions for healing and repair of connective tissue attachment |
| 04/01/1998 | EP0831881A1 Method for increasing hdl cholesterol level |
| 04/01/1998 | EP0831879A1 Method for identifying or isolating a molecule and molecules identified thereby |
| 04/01/1998 | EP0831875A1 Methods of inhibiting phagocytosis |
| 04/01/1998 | EP0831873A1 The treatment of hiv and other viral infections using combinatory therapy |
| 04/01/1998 | EP0831872A1 Polypeptide compounds that form beta sheets |
| 04/01/1998 | EP0831871A1 Relaxin-like factor and methods and uses thereof |
| 04/01/1998 | EP0831867A1 Collagen-based delivery matrix |
| 04/01/1998 | EP0831866A1 Pineal gland specific gene-1 |
| 04/01/1998 | EP0831689A1 Use of the indeterminate gametophyte gene for maize improvement |
| 04/01/1998 | EP0831688A1 Process for the preparation of antiviral plant transformed with lactoferrin gene |
| 04/01/1998 | EP0637318B1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 04/01/1998 | EP0507852B1 Gene deleted in colorectal cancer of humans |
| 04/01/1998 | CN1177982A System for the expression of heterologous antigens as fusion proteins |
| 04/01/1998 | CN1177980A Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 04/01/1998 | CN1177965A 角质形成细胞生长因子－2 Keratinocyte growth factor-2 |
| 04/01/1998 | CN1177909A Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 03/31/1998 | US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide) |
| 03/31/1998 | US5734037 DNA encoding the human cytokine, interleukin-9 |
| 03/31/1998 | US5734036 Nucleic acids encoding transcriptional activators |
| 03/31/1998 | US5734035 Nematode vaccine |
| 03/31/1998 | US5734034 Nucleic acid ligand inhibitors of human neutrophil elastase |
| 03/31/1998 | US5734026 Process for manufacturing crystals of growth hormone and crystals thereby obtained |
| 03/31/1998 | US5734024 Method for determining the biological activity of recombinant human growth hormone |
| 03/31/1998 | US5734023 Contacting isolated major histocompatibility complex chain component with an autoantigenic peptide such that the peptide is coupled to the antigen binding site to form a complex |